USA Financial Formulas’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,055
Closed -$230K 226
2019
Q4
$230K Sell
2,055
-2,865
-58% -$305K 0.1% 126
2019
Q3
$473K Buy
+4,920
New +$462K 0.18% 94
2018
Q4
Sell
-5,207
Closed -$381K 329
2018
Q3
$381K Buy
+5,207
New +$403K 0.1% 164
2015
Q4
Sell
-7,905
Closed -$377K 98
2015
Q3
$377K Sell
7,905
-6,540
-45% -$359K 0.24% 64
2015
Q2
$842K Buy
+14,445
New +$779K 0.26% 79

Other funds holding CNMD

USA Financial Formulas's CNMD Position: Q1 2020 in Review

USA Financial Formulas sold out of CONMED (CNMD) in Q1 2020, closing a stake of 2,055 shares — an estimated $230K sold.

USA Financial Formulas first reported a position in CNMD in Q2 2015 and held it in 5 quarters. The position peaked at $842K in Q2 2015. 229 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • USA Financial Formulas reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • USA Financial Formulas sold 2,055 CONMED shares in Q1 2020, an estimated $230K.
  • USA Financial Formulas first reported a position in CONMED in Q2 2015 and held it in 5 quarters.
  • USA Financial Formulas's CONMED position peaked at $842K in Q2 2015.
  • 229 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on USA Financial Formulas's 13F filing for Q1 2020, filed 13 Apr 2020.